Describing Real-World Rimegepant Utilization Patterns and Understanding Perceptions of Migraine Treatment Optimization from the Perspectives of Patients First published 31/07/2024 Last updated 25/06/2026 EU PAS number:EUPAS1000000232 Study Finalised